Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Reata Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€25.40
28.03.22
-
28.03.23
25.20%
02.04.22

Risky Investment
Global_Player 
28.03.22 50%
sell
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€21.16
28.03.22
-
28.03.23
-9.86%
02.04.22

Risky Investment
Vassago1 
28.03.22 50%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€66.35
25.03.22
-
25.04.22
6.07%
26.04.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
fenjal 
25.03.22 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€47.88
25.03.22
€64.00
25.03.23
-21.14%
27.03.23

Could be worthwhile Investment >10% per year
Einsiedler 
25.03.22 90%
buy
Ipsen S.A.

Start price
Target price
Perf. (%)
€112.45
25.03.22
-
25.03.23
-6.98%
27.03.23

GMSE 
25.03.22 50%
sell
Kineta Inc.

Start price
Target price
Perf. (%)
€12.46
24.03.22
-
24.03.23
-23.03%
02.04.22

Probably not worthwhile Investment
tinelchen 
24.03.22 0%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€48.26
23.03.22
€55.00
23.03.23
-3.61%
02.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
23.03.22 90%
sell
Palisade Bio Inc.

Start price
Target price
Perf. (%)
€59.50
22.03.22
-
22.03.23
-20.59%
31.03.22

Risky Investment
Global_Player 
22.03.22 50%
buy
Agenus Inc.

Start price
Target price
Perf. (%)
€2.54
22.03.22
-
22.03.23
-42.13%
21.05.22

Lector 
22.03.22 50%
buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€64.50
22.03.22
-
22.03.23
-43.57%
23.03.23

Saftman 
22.03.22 50%
buy
Voyager Therapeutics Inc

Start price
Target price
Perf. (%)
€7.65
21.03.22
€11.00
21.03.23
-7.01%
22.03.23

Could be worthwhile Investment >10% per year
Higher risks for its business
tbackenh 
21.03.22 50%
buy
PAVmed Inc

Start price
Target price
Perf. (%)
€1.35
21.03.22
€8.00
21.03.23
-14.92%
02.04.22

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Revenue decline/stagnation expected
Marianka 
21.03.22 70%
sell
Lipocine Inc.

Start price
Target price
Perf. (%)
€25.25
21.03.22
€0.000
21.03.23
-19.90%
02.04.22

Below average Management
high free float
High risks for its business
Unknown brand
Marianka 
21.03.22 70%
sell
PAVmed Inc

Start price
Target price
Perf. (%)
€1.41
20.03.22
-
20.03.23
-80.13%
21.03.23

Probably not worthwhile Investment
Lokrim 
20.03.22 20%
sell
Bovie Medical Corp

Start price
Target price
Perf. (%)
€6.45
20.03.22
-
20.03.23
-8.53%
28.05.22

Risky Investment
Lokrim 
20.03.22 20%
buy
Bayer AG

Start price
Target price
Perf. (%)
€57.80
18.03.22
-
18.03.23
4.83%
25.03.22

Mori8 
18.03.22 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€56.99
17.03.22
-
17.03.23
1.42%
18.03.22

Mori8 
17.03.22 50%
buy
Novocure Ltd

Start price
Target price
Perf. (%)
€64.20
16.03.22
€68.00
16.03.23
-6.99%
17.03.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
geldnutzer 
16.03.22 70%
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€54.20
16.03.22
€65.00
16.03.23
-43.24%
28.04.22

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
geldnutzer 
16.03.22 60%
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€21.29
16.03.22
€56.00
16.03.23
149.27%
17.03.23

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
geldnutzer 
16.03.22 60%
sell
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€81.03
15.03.22
-
15.03.23
-14.84%
20.03.22

Could be worthwhile Investment >10% per year
Vassago1 
15.03.22 50%
sell
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€20.53
14.03.22
€14.00
14.03.23
3.70%
16.03.22

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
geldnutzer 
14.03.22 60%
sell
Teladoc Health Inc

Start price
Target price
Perf. (%)
€46.58
14.03.22
€35.00
14.03.23
16.36%
16.03.22

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
geldnutzer 
14.03.22 60%
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€4.81
14.03.22
€6.40
14.03.23
-33.68%
11.06.22

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
geldnutzer 
14.03.22 50%
buy
Eurobio scientific

Start price
Target price
Perf. (%)
€19.28
14.03.22
€21.00
14.03.23
-10.58%
05.10.22

Could be worthwhile Investment >10% per year
melinda 
14.03.22 50%